阿茲海默症治療藥的中國市場
市場調查報告書
商品編碼
86316

阿茲海默症治療藥的中國市場

Alzheimer Disease Drugs Markets in China

出版日期: | 出版商: Asia Market Information & Development Co. | 英文 239 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

本報告提供中國的阿茲海默症治療藥市場相關調查分析,提供需求與產業趨勢的預測,及商業環境,打入市場的相關資訊。

目錄

第1章 簡介

  • 調查範圍和調查手法
  • 摘要整理

第2章 商業環境

  • 經濟預測
  • 主要經濟指標
  • 工業生產
  • 人口和勞動力
  • 外國投資
  • 國際貿易
  • 財務和稅金的法規
  • 銀行系統和法規
  • 外匯
  • 稅金和關稅

第3章 阿茲海默症治療藥產業的評估

  • 阿茲海默症治療藥產業結構
  • 市場規模
  • 推動市場要素
  • 阿茲海默症治療藥的銷售量
  • 主要的生產設施的場所和銷售量
  • 主要生產者的市場佔有率
  • 人事費用
  • 潛在的參與企業
  • 主要的銷售商
  • 主要的國外投資
  • 技術開發

第4章 阿茲海默症治療藥的生產和需求

  • 概要
  • 阿茲海默症治療藥的需求:各地區
  • 阿茲海默症治療藥的銷售量
  • 銀杏萃取物
  • Breviscapine
  • Ganglioside
  • Donepezil
  • Galanthamine
  • Nicergoline
  • Rivastigmine
  • Memantine
  • Huperzine A
  • Oxiracetam
  • Flunarizine
  • Piracetam
  • 其他的阿茲海默症治療藥
  • 阿茲海默症治療藥的進口
  • 銀杏萃取物的進口
  • Breviscapine的進口
  • Ganglioside的進口
  • Donepezil的進口
  • Galanthamine的進口
  • Nicergoline的進口
  • Rivastigmine的進口
  • Memantine的進口
  • Huperzine A的進口
  • Oxiracetam的進口
  • Flunarizine的進口
  • Piracetam的進口
  • 其他的阿茲海默症治療藥的進口
  • 價格趨勢

第5章 阿茲海默症治療藥市場預測

  • 阿茲海默症治療藥市場預測概要
  • 政府的法規
  • 醫療保險產業概要
  • 消費者支出趨勢:各地區
  • 人口動態趨勢
  • 醫療產業趨勢
  • 醫院和病床
  • 醫生與受診

第6章 行銷策略

  • 中國市場進入概要
  • 中國的流通系統
  • 阿茲海默症治療藥的流通管道
  • 運輸和貨物的基礎設施
  • 通訊
  • 中國市場進入
  • 授權
  • 專利權
  • 電子商務
  • 公司和現場的代理店
  • 代表辦事處和中國的子公司
  • 完全外資企業

第7章 阿茲海默症治療藥生產者名錄

  • 主要的阿茲海默症治療藥生產者的簡介
  • 銷售商·公司
  • 協會·研究機關
  • 主要的終端用戶
Product Code: 801

China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Alzheimer's Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Alzheimer's Disease Drugs by Region
  • Alzheimer's Disease Drugs Sales Volume
  • Ginkgo Bilota Extract
  • Breviscapine
  • Ganglioside
  • Donepezil
  • Galanthamine
  • Nicergoline
  • Rivastigmine
  • Memantine
  • Huperzine A
  • Oxiracetam
  • Flunarizine
  • Piracetam
  • Other Alzheimer's Disease Drugs
  • Alzheimer's Disease Drugs Imports
  • Ginkgo Bilota Extract Imports
  • Breviscapine Imports
  • Ganglioside Imports
  • Donepezil Imports
  • Galanthamine Imports
  • Nicergoline Imports
  • Rivastigmine Imports
  • Memantine Imports
  • Huperzine A Imports
  • Oxiracetam Imports
  • Flunarizine Imports
  • Piracetam Imports
  • Other Alzheimer's Disease Drugs Imports
  • Pricing Trend

V. ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK

  • Alzheimer's Disease Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends By Region
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

V. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. ALZHEIMER'S DISEASE DRUGS PRODUCER DIRECTORY

  • Major Alzheimer's Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Associations and Research Institutes
  • Major End-Users

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Alzheimer's Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investments

IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

  • Total Alzheimer's Disease Drugs Sales Volume
  • Alzheimer's Disease Drugs Major Producer and Their Market Share
  • Ginkgo Bilota Extract Major Producer and Their Market Share
  • Breviscapine Major Producer and Their Market Share
  • Ganglioside Major Producer and Their Market Share
  • Donepezil Major Producer and Their Market Share
  • Galanthamine Major Producer and Their Market Share
  • Dihydroergotamine Major Producer and Their Market Share
  • Rivastigmine Major Producer and Their Market Share
  • Memantine Major Producer and Their Market Share
  • Huperzine A Major Producer and Their Market Share
  • Oxiracetam Major Producer and Their Market Share
  • Flunarizine Major Producer and Their Market Share
  • Piracetam Major Producer and Their Market Share
  • Alzheimer's Disease Drugs Import

V. ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK

  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Alzheimer's Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China's Imports and Exports

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Sales Volume

II. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND

  • DEMAND
  • Alzheimer's Disease Drugs Sales Volume
  • Worldwide Alzheimer's Disease Drugs Demand by Region
  • Ginkgo Bilota Extract Sales Volume and Market Share
  • Breviscapine Sales Volume and Market Share
  • Ganglioside Sales Volume and Market Share
  • Donepezil Sales Volume and Market Share
  • Galanthamine Sales Volume and Market Share
  • Dihydroergotamine Sales Volume and Market Share
  • Rivastigmine Sales Volume and Market Share
  • Memantine Sales Volume and Market Share
  • Huperzine A Sales Volume and Market Share
  • Oxiracetam Sales Volume and Market Share
  • Flunarizine Sales Volume and Market Share
  • Piracetam Sales Volume and Market Share
  • Other Alzheimer's Disease Drugs Sales volume and market share
  • Alzheimer's Disease Drugs Import Volume
  • Ginkgo Bilota Extract Import Volume and Market Share
  • Breviscapine Import Volume and Market Share
  • Ganglioside Import Volume and Market Share
  • Donepezil Import Volume and Market Share
  • Galanthamine Import Volume and Market Share
  • Dihydroergotamine Import Volume and Market Share
  • Rivastigmine Import Volume and Market Share
  • Memantine Import Volume and Market Share
  • Huperzine A Import Volume and Market Share
  • Oxiracetam Import Volume and Market Share
  • Flunarizine Import Volume and Market Share
  • Piracetam Import Volume and Market Share
  • Other Alzheimer's Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel